Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
Conditions: Facioscapulohumeral Muscular Dystrophy; Charcot-Marie-Tooth Disease Intervention: Drug: ACE-083 Sponsor: Acceleron Pharma, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials